Research Funding

NCSAR Pilot Grant Program

Deadline:  Friday, July 28, 2017

The NCSAR pilot grant is designed to support innovative pre-clinical translational and clinical research projects to improve investigation, diagnosis and treatment of substance abuse related disorders.

This first request for applications focuses on substance abuse and its consequences on the biological functioning within the CNS, with the ultimate goal of developing therapeutic strategies aimed at preventing and treating drug addiction and the associates co-morbidities.

Information on this opportunity can be found on the NCSAR website

Questions may be directed to:

Shilpa Buch, Ph.D.
NCSAR Director
University of Nebraska Medical Center
402-559-3165

Sara Dejano
Office Assistant to Dr. Buch
University of Nebraska Medical Center
402-559-9523

Nebraska Center for Substance Abuse Research Pilot Grant

Due Date: July 28, 2017

The Nebraska Center for Substance Abuse Research (NCSAR) was established in 2015 with a mission to bring the power of science and research to bear on drug abuse and addiction, thereby improving the quality of life of the affected individuals, while reducing the health care costs in the state of Nebraska through innovative collaborative basic and clinical research, premier education programs, and outreach to those suffering from addiction.

The objective of the NCSAR pilot grant is designed to support innovative pre-clinical translational and clinical research projects to improve investigation, diagnosis and treatment of substance abuse related disorders. This first request for applications focuses on substance abuse and its consequences on the biological functioning within the CNS, with the ultimate goal of developing therapeutic strategies aimed at preventing and treating drug addiction and the associates co-morbidities.

More information and the application can be found here:
https://www.unmc.edu/ncsa/research/funding.html

Eligibility: To be eligible for a NCSAR pilot grant, you must

  • possess a doctoral-level degree
  • have an academic appointment at or above the instructor (faculty appointment) level at one of our member institutions
  • be eligible to apply for an independent NIH R application

Established investigators in another field applying their expertise to drug abuse and addiction and meet the above criteria are welcome to apply. Applications must adhere to several criteria and will undergo a rigorous, objective review process.

Funding: Pilot grants are available up to $30,000 for one year.

Three grants will be awarded

  • one for pain research at UNMC
  • two for other substance abuse work; interdisciplinary and interinstitutional collaborations will be prioritized.

Pilot grants awarded are funded for up to one calendar year from the award date. If you have questions, please contact us.

Deadline: Applications must be sent as a PDF file to Sara Dejano before 4:00 p.m. Central Daylight Time, Friday, July 28, 2017.  Each applicant will receive a notice that his/her application has been received. If you have not received this receipt e-mail, please contact Sara Dejano.

DoD Spinal Core Injury Research Program

FY17 SCIRP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov.

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA), J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

 

Clinical Research Development Award – Preproposal due August 8, 2017

Independent investigators at all academic levels (or equivalent)

  • Preproposal is required; application submission is by invitation only.
  • Fund research that will establish the necessary collaborations and develop the necessary research resources that will serve as a foundation for investigator-initiated clinical research.
  • Clinical trials not allowed.
  • Maximum funding of $100,000 for direct costs (plus indirect costs)
  • Maximum period of performance is year

 

Clinical Trial Award – Preproposal due August 8, 2017

Independent investigators at all academic levels (or equivalent)

  • Preproposal is required; application submission is by invitation only.
  • Fund Phase 0, I, or II clinical trials with the potential to have a major impact on treatment or management of spinal cord injury (SCI) and its consequences.
  • Preclinical data required for all clinical trial applications.
  • Maximum funding of $2,000,000 for direct costs (plus indirect costs)
  • Maximum period of performance is years

 

Investigator-Initiated Research Award – Preproposal due August 8, 2017

Independent investigators at all academic levels (or equivalent)

  • Preproposal is required; application submission is by invitation only.
  • Fund SCI-related research that has the potential to make an important contribution to SCI research and/or patient care.
  • Preliminary data required.
  • Clinical trials not allowed.
  • Maximum funding of $500,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 3 years

 

Qualitative Research Award – Preapplication due August 8, 2017

Independent investigators at all academic levels (or equivalent)

  • Preproposal is required; application submission is by invitation only.
  • Fund qualitative research on military Service members and Veterans in the years following SCI.
  • Qualitative research is defined as a form of social inquiry that focuses on understanding the way that people interpret and make sense of their experiences and the world in which they live (i.e., seek to understand the human experience).
  • Preliminary data encouraged, but not required.
  • Clinical trials not allowed.
  • Maximum funding of $500,000 for direct costs (plus indirect costs)
  • Maximum period of performance is years

Translational Research Award – Preproposal due August 8, 2017

Independent investigators at all academic levels (or equivalent)

  • Preproposal is required; application submission is by invitation only.
  • Fund studies that accelerate the movement of promising ideas in SCI research into clinical applications.
  • Optional Feature:  Applications that include a Qualified Collaborator that meets criteria identified in the announcement may apply for a higher level of funding.
  • Preliminary data required.
  • Limited clinical testing of a novel intervention or device is permissible.
  • Maximum funding of $1,250,000 for direct costs (plus indirect costs)
  • Maximum funding of $1,500,000 for direct costs (plus indirect costs) for applications including an Optional Qualified Collaborator
  • Maximum period of performance is years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 

Applications must be submitted through the Federal Government’s single-entry portal, Grants.gov.  For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the SCIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org